AGT and cardiovascular disorder: Particularly, long-term over-activation of RAAS predominantly participates in cardiac remodeling and progressive deterioration of CHF.15 As a specific Ang II receptor-blocking agent; valsartan can postpone the development of cardiovascular disease by effectively inhibiting Ang II or aldosterone escape, with the maximum effective rate of only about 90% though.16